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Synopsis: A review of the complete diagnosis of the types of twinning and 
subsequent ultrasonography management of the twin gestation. 
 
Abstract 
Twins represent 1%–2% of all pregnancies, yet continue to account for a 
disproportionate share of neonatal adverse events including neonatal intensive care 
admission, morbidity, and mortality. Ultrasonography is central to the proper 
diagnosis of the type of twinning. Ideally, ultrasonography is performed before 14 
weeks of gestation to determine chorionicity and amnionicity. Correct identification of 
the chorionicity in a twin pregnancy facilitates proper counseling and management of 
the gestation, including ultrasonography follow-up. Herein, the different types of Au
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twinning are reviewed, together with the implications for ultrasonography monitoring 
of each specific type of twin gestation. 
 
1 INTRODUCTION 
The increasing incidence of twin pregnancies reinforces the need for clinicians to 
understand the appropriate evaluation and management of multiple gestations. 
Ultrasonography is integral for appropriate diagnosis and surveillance, facilitating the 
optimization of care for the pregnancy. 
 
The rate of twins in high-income countries ranged from 14.6 to 21.2 per 1000 
deliveries in 2011 [1]. Twins are responsible for a disproportionate share of 
pregnancy-related complications. Most adverse events relate to the high risk of 
prematurity; in Europe, the median preterm delivery rate (<37 weeks of gestation) in 
multiples is 53% and among very preterm deliveries (<32 weeks) is 9% [2]. 
Additional problems are related to growth anomalies, discordant fetal anomalies, or 
the many potential adverse events of monochorionic twinning, all of which can be 
detected by prenatal imaging. The role of ultrasonography in the accurate diagnosis 
and management of twin gestations is explored in the present review. 
 
2 ETIOLOGY OF TWINS 
Twins develop either from two fertilized eggs implanting into the uterus (dizygotic) or 
from a single fertilized egg that splits early in pregnancy (monozygotic). Although 
most twins are dizygotic, one-third are monozygotic or “identical” [3]. All dizygotic 
twins have functionally separate placentas and are dichorionic/diamniotic. Dizygotic 
twins carry less risk than monozygotic twins; however, the risk is greatest for 
monozygotic twins that share a placenta (monochorionic). Ultrasonography cannot 
always clarify zygosity. Dichorionic twins with discordant genders are known to be 
dizygotic. However, the zygosity of dichorionic same-gender twins is not obvious 
because 30% of monozygotic twins are dichorionic [4].  
 
For monozygotic twins, the day on which the embryo splits after fertilization 
determines chorionicity (Table 1) [3]. An embryo splitting on day 1–3 after fertilization 
results in dichorionic/diamniotic twins. If the embryo splits on day 4–7, 
monochorionic/diamniotic twins develop. Splitting on day 8–12 leads to 
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monochorionic/monoamniotic twins; less than 2% of monozygotic pregnancies are 
monoamniotic. Conjoined twins result from the embryo splitting 13–16 days after 
conception.  
 
Approximately 80%–90% of spontaneously conceived twin pregnancies are 
dichorionic [4]. The incidence of monochorionic twins is higher among pregnancies 
achieved by assisted reproductive technology, especially in vitro fertilization, and is 
even higher among those resulting from transfer of day 5 blastocysts [5]. 
 
3 CHORIONICITY AND AMNIONICITY 
Identifying chorionicity in the first trimester is extremely important. The number of 
chorions (placentas) and amnions (inner membranes covering the embryo) has the 
largest impact on both pregnancy risk and determination of the management for that 
gestation.  
 
Chorionicity is best determined by ultrasonography before 14 weeks of gestation and 
has an accuracy of 99% [6, 7]. In a dichorionic pregnancy at less than 8 weeks of 
gestation, the two gestational sacs can appear completely separated (Figure 1) [8]. 
The appearance of the placentas for dizygotic twins between 8 and 14 weeks 
depends on the location of placental implantation [9]. If the placentas implant away 
from each other, they will have the appearance of two distinct placentas. Separate 
placentas can be seen in approximately one-third of twin gestations [9]. However, if 
the implantations occur close together, the placentas can appear fused, similar to a 
single placenta with a twin peak or lambda sign seen in the intervening membrane 
(Figure 2) [8, 10].  
 
The presence of a single chorion in monochorionic twins can be easily identified 
throughout the first trimester (Figure 3) [8]. The intervening membrane, created by 
two amnions (Figure 4), is more challenging to visualize and sometimes is not 
identifiable in the early first trimester [11, 12]. If the amnion is not identified in early 
gestation, follow-up ultrasonography should be performed before 14 weeks of 
gestation to confirm amnionicity. The presence of a T sign where two opposing 
amnions meet at the edge of the placenta is diagnostic of a 
diamniotic/monochorionic gestation (Figure 5) [13]. The inability to identify an 
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intervening membrane, along with the presence of intertwined umbilical cords, 
confirms a monochorionic/monoamniotic pregnancy (Figures 6 and 7). 
 
If an ultrasonography examination has not been performed before 14 weeks of 
gestation to determine chorionicity, ultrasonography determination of chorionicity 
should be attempted at the time of presentation. In approximately 14% of dichorionic 
pregnancies, the lambda sign will disappear by 20 weeks of gestation [14]; however, 
in the majority of cases, it will still be visible. Ultrasonography determination of 
chorionicity in the second trimester (<24 weeks) has a positive predictive value of 
95% [15]. In addition to the lambda sign, gender can be used to determine 
chorionicity. Except in rare cases, different fetal genders imply dichorionic twins.  
 
The number of placentas is more challenging to assess as pregnancy progresses. 
Two separate placentas usually represent dichorionic twins. In approximately 3% of 
monochorionic twins, however, the placenta appears as two separate masses [16]; 
in addition, dichorionic placentas can fuse. Dichorionic twins have four intervening 
membranes (two chorions and two amnions) as compared with two intervening 
membranes (two amnions) in monochorionic twins. Although membrane thickness 
has been proposed as a method to determine chorionicity, it is a poor single 
predictor of chorionicity, with a specificity of only 85% based on a cut-off membrane 
thickness of 2 mm or more [17]. If the chorionicity of the pregnancy cannot be 
determined, the pregnancy should be classified as “presumed monochorionic,” and 
monitored and managed as such for the remainder of the gestation. 
 
Not only is early ultrasonography crucial for assessing chorionicity, but it is also 
recommended for accurate pregnancy dating. As in singleton pregnancies, if the 
crown rump length (CRL) is consistent with a sure last menstrual period (LMP), the 
LMP should be used for pregnancy dating. The larger CRL should be used for dating 
if the CRLs of the two fetuses are discordant [18]. If the first ultrasonography 
examination is not performed until after 14 weeks, biometric parameters should be 
used to determine gestational age rather than CRL [19]. Again, the larger head 
circumference should be used to determine pregnancy dating if the biometric 
parameters of the two fetuses are discordant [18]. Correct chorionicity and accurate 
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pregnancy dating are both important in assisting the correct timing and interpretation 
of screening tests, diagnostic tests, and timing of delivery.  
 
3.1 Diamniotic/dichorionic twins 
Dichorionic/diamniotic gestation and pregnancy dating are ideally determined in the 
first trimester. Aneuploidy screening should be offered in twin gestations just as in 
singleton gestations. Although its detection rates are lower than those observed for 
singleton pregnancies, first-trimester combined screening by nuchal translucency 
and serum analytes (free β-human chorionic gonadotropin, pregnancy associated-
plasma protein-A) has a detection rate for Down syndrome of 70%–72% with a 5% 
false-positive rate for twins [20]. Cell-free DNA screening is also available for twin 
gestations [21]. The American Congress of Obstetricians and Gynecologists does 
not recommend the use of cell-free DNA screening in multiple gestations [22]; 
however, the American College of Medical Genetics recommends discussing the 
validity of cell-free DNA screening with the laboratory before offering the test to 
women with multiple gestations [23]. 
 
Routine anatomic evaluation should be performed at the same gestational age 
applied to singletons. Dichorionic twins have a slightly higher rate of fetal anomalies 
(3%) as compared with singletons (2%) [24]. Placenta previa is more common in 
dichorionic gestations; this is probably due to the increased placental mass [26]. In 
addition to placental location, placental cord insertions should also be evaluated. The 
rate of velamentous cord insertion (VCI), where the umbilical cord is inserted within 
the fetal membranes, is 8% in dichorionic twins [27]. It occurs in both twins in nearly 
1% of dichorionic twin pregnancies, and has been associated with an increased rate 
of intrauterine growth restriction [27, 28]. A single umbilical artery, which is also 
associated with decreased growth, is three times more common in twin than in 
singleton gestations [29]. 
 
Serial ultrasonography examinations every 4–6 weeks are recommended to assess 
fetal growth, size concordance, and amniotic fluid volume [18]. Growth discordance 
is calculated by the difference in the estimated twin weights divided by the weight of 
the larger twin, and is expressed as a percentage. Although variations in the 
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definition of discordance range from 18% to 25%, in general, a growth discordance 
greater than 20% is associated with a higher incidence of adverse outcomes [18, 
30]. Discordant growth is seen in 7%–18% of dichorionic gestations and can be 
related to differential placental mass, cord insertion, placental implantation sites, or 
underlying differences in genetic growth potential [31]. 
 
3.2 Diamniotic/monochorionic twins 
Similar to dichorionic twinning, first-trimester ultrasonography before 14 weeks of 
gestation is required in monochorionic twins to define chorionicity, date the 
pregnancy, and facilitate appropriate counseling and management of the pregnancy 
[6]. The frequency of complications is higher for monochorionic twins than for 
dichorionic twins owing to the shared placenta with vascular anastomoses. All 
monochorionic twins share anastomoses, with differential risks to each twin. In light 
of these known connections, single intrauterine fetal demise (IUFD) has an impact 
on the remaining fetus, including 10%–15% risk of co-twin demise and 10%–30% 
chance of neurologic injury [32]. Placental vascular anastomoses also result in risks 
that are unique to monochorionic twins. For example, there is 10% risk of twin-to-
twin transfusion syndrome (TTTS), 10% risk of selective intrauterine growth 
restriction (sIUGR), 3% risk of twin anemia polycythemia sequence (TAPS), and 1% 
risk of twin reversed arterial–perfusion (TRAP) sequence [30]. Discordant CRL 
(≥10%) in the first trimester could be a marker for increased risk of structural or 
chromosomal anomalies, single IUFD, pregnancy loss, TTTS, or sIUGR [33]. 
 
As in dichorionic twinning, first-trimester screening can be used in monochorionic 
twinning and has a detection rate for trisomy 21 of approximately 84% with a 5% 
false-positive rate [20]. Regarding nuchal translucency alone, the rate of positive 
results is higher for monochorionic twins than for dichorionic twins [34]. This is 
thought to be related to the higher incidence of structural anomalies among 
monochorionic twins, as well as the possible association with TTTS risk. Discordant 
nuchal translucency findings (≥20%) are more concerning in cases of monochorionic 
twinning and have a 30% risk of early fetal death or TTTS [35]. Cell-free DNA can 
also be considered for aneuploidy screening in monochorionic gestations [21-23]. 
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Identification of the cord insertion site into the placenta is important in monochorionic 
twinning. Not only is VCI more frequent in monochorionic twinning, but it is also 
associated with higher risks of sIUGR [28]. The increased incidence of VCI results in 
more frequent vasa previa, highlighting the importance of evaluating fetal vessels 
traversing near the cervix to rule out this condition in cases of lower uterine segment 
cord insertion [36]. Transvaginal ultrasonography can be helpful for confirming or 
ruling out vasa previa when VCI is noted at the lower margin of the placenta (Figure 
8).  
 
The incidence of congenital anomalies is approximately two-fold higher in 
monochorionic twins (approximately 6%) than in dichorionic twins (approximately 
3%) [24]. The most frequent anomaly is congenital heart disease, which occurs in 
approximately 5% of monochorionic twin pregnancies [37]. Owing to this increased 
rate of heart disease, fetal echocardiography is recommended for all monochorionic 
pregnancies [37, 38]. Despite monozygosity, most anomalies are discordant, with 
90% of twin pregnancy anomalies occurring in only one twin [25]. When both twins 
have anomalies, the same structural anomaly is present approximately 20% of the 
time [25].  
 
Owing to the risk of complications in monochorionic twins, serial ultrasonography 
examinations should be initiated at 16 weeks of gestation and continued at a 
minimum of every 2 weeks until delivery [30, 39, 40]. Serial scans are performed to 
evaluate amniotic fluid volume and Doppler velocimetry is used to determine the 
development of TTTS. Growth should be measured at a minimum of every 4 weeks, 
with more frequent surveillance or inclusion of umbilical artery Doppler velocimetry 
when there is discordant fluid, growth discordance or restriction, or other concerns 
[38]. 
 
3.2.1 Twin-to-twin transfusion syndrome 
TTTS occurs in 10% of monochorionic twins; it is diagnosed by the presence of 
polyhydramnios in one fetus and oligohydramnios in the co-twin. The donor twin 
typically appears to be “stuck” to the uterine wall or placenta. Frequently, the 
intervening membrane is challenging to identify because it is so close to the donor. 
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Errors in assessment can occur if the lack of fluid around the donor is not 
appreciated (Figure 9).  
 
Once a diagnosis is made, the stage of TTTS can be determined by using the 
system developed by Quintero et al. [41] (Table 2). Stage I is polyhydramnios and 
oligohydramnios. Stage II is non-visualization of the fetal bladder in the donor twin 
for more than 60 minutes. Stage III includes pregnancies with abnormal Doppler 
measurements. Stage IV results when hydrops is present in one or both of the twins. 
Stage V is the death of one or both fetuses. If an absent bladder, Doppler 
velocimetry anomaly, or hydrops is observed without both polyhydramnios and 
oligohydramnios, the diagnosis is not TTTS and other possibilities should be 
considered, such as sIUGR or a fetal anomaly.  
 
The staging system is helpful for counseling and determining appropriate treatment 
options. Additional information regarding cardiac function aids in counseling. 
Identification of placental cord insertions, if not previously performed, is important 
because proximate cord insertions can preclude fetoscopic laser ablation of the 
communicating vessels as a treatment option (Figure 10). 
 
Owing to the high mortality without treatment (73%–100%, depending on stage and 
gestational age at diagnosis), intervention is recommended for TTTS and the most 
favorable outcomes are achieved with selective fetoscopic laser photocoagulation 
(sFLP) [30, 42-44]. When TTTS is diagnosed, patients should be referred to a fetal 
therapy center for further counseling on the management of TTTS, including the 
risks and benefits of sFLP. The sFLP procedure can be performed between 16 and 
26 weeks of gestation [44] and involves laser coagulation of the communicating 
vessels between the twins to functionally separate the placenta for each twin [44]. At 
the end of laser ablation, amnioreduction is performed to normalize the fluid in the 
recipient twin’s sac [44]. 
 
After laser treatment, the pregnancy needs continual close surveillance. Serial 
ultrasonography examinations should be performed to assess amniotic fluid volume, 
bladder size, and Doppler velocimetry to monitor for post-laser TAPS, recurrence of 
TTTS, or IUFD [30]. Historically, post-laser TAPS has occurred in approximately 
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10% of TTTS cases, but the incidence is lower since the introduction of the Solomon 
technique, which involves coagulation of the whole vascular equator to ablate any 
small vessels or micro-anastomoses that might not be apparent, providing complete 
functional separation of the portions of the placenta [45].  
 
Preterm premature rupture of membranes (PPROM) occurs in approximately 30% of 
pregnancies that undergo sFLP [46]. Approximately half of affected women will 
deliver within 24 hours of PPROM and the mean latency period is 2 weeks [47]. 
Unintentional septostomy occurs in approximately 6% of patients undergoing sFLP; 
this can convert the pregnancy into a monoamniotic pregnancy with the associated 
risks [48]. If there is fetal demise, the surviving co-twin should have an assessment 
of intracranial structures because ventriculomegaly could be a sign of neurologic 
damage. When membrane separation occurs after sFLP, it is associated with an 
increased risk of PPROM [50]. 
 
3.2.2 Selective intrauterine growth restriction 
sIUGR affects 10% of monochorionic pregnancies and can be caused by unequal 
placental sharing, VCI, or discordant splitting of the zygote [51]. Prognosis is 
determined by the degree of discordance and the presence or absence of Doppler 
anomalies [52]. The same definition of growth discordance used in dichorionic twins 
applies to monochorionic gestations (intertwin estimated fetal weight discordance 
ranging from 18% to 25%, or an estimated fetal weight of less than 10% for one twin) 
[30].  
 
Gratacos et al. [52] have classified monochorionic sIUGR pregnancies as three 
types. Type I, with positive end diastolic flow in the umbilical artery of the IUGR twin, 
is associated with 5% risk of intrauterine demise and intact survival of both twins in 
more than 90% of monochorionic sIUGR pregnancies. The average gestational age 
at delivery is 35 weeks in type I pregnancies. Type II is defined by persistently 
absent or reversed end diastolic flow in the umbilical artery of the smaller twin 
(Figure 11) [52]. Type II has greater discordance (average 38%) and an earlier mean 
age of delivery at 31 weeks [52]. In type III, a variable pattern of intermittently absent 
or reversed end diastolic flow is interspersed with forward end diastolic flow with a 
worse prognosis [52]. The average age at delivery is 31–32 weeks. Unfortunately, in 
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cases of type III sIUGR, prenatal testing is not predictive of fetal demise and there is 
21% risk of IUFD [52]. In the presence of sIUGR, weekly umbilical artery Doppler 
velocimetry should accompany prenatal testing to assist in determining the timing of 
delivery [18]. 
 
3.2.3 Twin anemia polycythemia sequence 
Twin anemia polycythemia sequence is caused by a chronic net transfusion of blood 
from one fetus to the other, usually through small unidirectional anastomoses within 
a monochorionic placenta [45]. TAPS is characterized by significant discordance in 
hemoglobin levels between monochorionic twins, resulting in discordant peak 
systolic Doppler velocity of the middle cerebral artery. TAPS occurs spontaneously in 
approximately 3% of monochorionic twins, and is most often diagnosed after 26 
weeks of gestation. TAPS can also develop after sFLP for TTTS, most commonly 1–
5 weeks after the procedure [54].  
 
Diagnosis requires a Doppler peak systolic velocity of the middle cerebral artery of 
more than 1.5 multiples of the median in one fetus and less than 1.0 in the co-twin; 
these findings occur in the absence of polyhydramnios–oligohydramnios, which is 
diagnostic of TTTS [45]. The staging for TAPS is summarized in Table 3 [45]. 
Treatment is dependent on gestational age, but can include continued observation, 
intrauterine fetal transfusion, sFLP, or delivery with postnatal treatment [45]. 
Currently, the best treatment for TAPS has not been established [53].  
 
3.2.4 Twin reversed arterial perfusion  
Twin reversed arterial perfusion sequence occurs in 1% of cases of monochorionic 
twinning [55]. A pump twin supports the co-twin through unidirectional arterial–
arterial anastomosis within the shared single placenta. Deoxygenated blood flows in 
a retrograde manner from the pump twin into a non-pump twin with abnormal 
development (Figure 12). The non-pump twin is typically acephalus and acardiac, 
with more development of the lower extremities relative to the upper extremities [56].  
 
Presentation can range from a large amorphous tissue mass to the presence of 
cranial tissue, a rudimentary heart with cardiac activity, and all four extremities [56]. 
Documenting the reversed blood flow in the umbilical artery is key in diagnosis. 
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During first-trimester ultrasonography, the acardiac twin can be misdiagnosed as a 
fetal demise owing to a lack of cardiac activity on real-time scanning [56]. Any case 
of first-trimester fetal demise in monochorionic twins should have a Doppler 
evaluation for reversal of flow in the umbilical artery in the demised twin to rule out 
TRAP sequence [56]. If TRAP is diagnosed, serial ultrasonography examinations 
should be performed to monitor the relative size of the acardiac twin and the heart 
function of the pump twin [30].  
 
The pump twin is at increased risk of perinatal mortality (up to 55%) owing to high-
output cardiac failure caused by the cardiac demands of supporting the acardiac twin 
and prematurity associated with polyhydramnios [55]. The outcome depends on the 
relative size of the pump twin and the acardiac twin. The twin weight ratio is 
calculated by comparing the ratio of the acardiac twin to the pump twin, using a 
prolated ellipsoid formula (width × height × length [in cm] × 0.523) to estimate the 
acardiac twin’s mass [57]. If the size of the acardiac twin is more than 50% of that of 
the pump twin, procedures that halt the flow of blood to the acardiac twin can lead to 
better outcomes with 80% survival of the pump twin [55, 57]. When a diagnosis of 
TRAP occurs, referral to a fetal therapy center is important to discuss interventions, 
including cord coagulation or radiofrequency ablation [57]. Careful anatomic survey 
of the pump twin should be undertaken because there is a 5%–10% risk of structural 
anomalies, most commonly congenital heart disease [56]. Amniocentesis should be 
offered in cases of TRAP owing to the 9% risk of chromosomal anomalies [58]. 
 
3.3 Monoamniotic/monochorionic twins 
The diagnosis of monoamniotic twins is determined by the lack of an amniotic 
membrane separating the fetuses in a monochorionic gestation. As mentioned 
above, the intertwin membrane is often thin and can be difficult to visualize before 12 
weeks. If it is not visualized on the initial ultrasonography, the intertwin membrane 
should continue to be looked for on subsequent scans. Monoamniotic twins can have 
cord entanglement, which can help confirm the diagnosis (Figure 13) [59].  
 
Interestingly, the incidence of female fetuses in monoamniotic gestations is higher 
(>70%) [60]. This is thought to be related to X inactivation in female embryos, which 
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causes a slight temporal delay in the twinning process, with a bias toward 
monoamnionicity [60]. Historically, monoamniotic twins had perinatal mortality rates 
as high as 68% [61]. This was mostly attributed to umbilical cord entanglement but 
was also influenced by congenital anomalies and prematurity [61]. With the current 
practice of intensive fetal surveillance beginning with intent for intervention, survival 
is approximately 80% [59]. Both inpatient and outpatient monitoring have been noted 
to have similar outcomes [62]. Among pregnancies that achieve a gestational age 
consistent with anticipated potential viability, the perinatal mortality rate is more 
closely related to gestational age at delivery and the presence of anomalies. 
 
Monoamniotic gestations have a significantly higher risk of congenital anomalies 
(10%–30%) and congenital heart defects (4%) [63]. A detailed anatomic survey 
coupled with fetal echocardiogram is therefore appropriate.  
 
Although small, there is a 6% risk of TTTS in monoamniotic twins, which is most 
probably related to the increased presence of arterioarterial anastomoses and fewer 
deep arteriovenous anastomoses [63, 64]. The usual criteria of polyhydramnios and 
oligohydramnios cannot be used for the diagnosis of TTTS in light of the shared 
single sac. Thus, a maximum vertical pocket greater than 8 cm before 20 weeks of 
gestation or greater than 10 cm after 20 weeks, along with discordant bladder filling, 
is used to diagnose TTTS.  
 
3.4 Conjoined twins 
Conjoined twins occur in less than 1% of monozygotic twins and have a higher 
incidence in Southeast Asia and Africa [65]. Similar to monoamniotic/monochorionic 
twins, most conjoined twin live births are female, with a 3:1 female-to-male ratio. 
Conjoined twins should be suspected in a monochorionic/monoamniotic twin 
pregnancy where the fetuses hold the same relative position to each other 
throughout the ultrasonography [66]. Other ultrasonography findings suggesting 
conjoined twins include more than three vessels in the umbilical cord, hyperflexion of 
the spine, and bifid appearance of the fetal pole [67]. After 8 weeks of gestation, fetal 
activity typically increases, allowing for improved differentiation between 
monoamniotic twins and conjoined twins [67].  
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Classification of conjoined twins is based on the most prominent site of union [68]. 
Conjoined twins are specified into eight types: cephalopagus (fused from vertex to 
umbilicus), thoracopagus (ventrally from upper thorax to umbilicus), omphalopagus 
(ventrally in the abdomen), ischiopagus (umbilicus to large conjoined pelvis), 
parapagus (ventrolateral fusion sharing umbilicus, lower abdomen, pelvis, and 
genitourinary tract), craniopagus (any part of skull), pyopagus (dorsally sharing 
sacrococcygeus and perineum), and rachipagus (dorsal fusion that can extend from 
occiput down to above sacrum) [69, 70].  
 
Conjoined twins tend to have more anomalies than non-conjoined monozygotic 
twins. Malformations occurring in conjoined twins are not only related to junction 
regions, but also develop away from junctional sites [71]. Additional imaging 
modalities, including echocardiogram and magnetic resonance imaging, have been 
used to assist in delineating shared anatomy in order to optimize counseling on 
management and planning for delivery and postnatal care [72].  
 
The prognosis for conjoined twins is poor. For ongoing pregnancies, there is a 10%–
50% risk of IUFD, and fewer than half of live-delivered twins survive [68, 71], with a 
third dying within 24 hours of delivery [74, 72]. Separation is unlikely to be successful 
and typically not attempted in twins with complex cardiac fusion or extensive cerebral 
fusion [69]. Thoracopagus and parapagus twins have the lowest survival rate after 
separation, while craniopagus and pyopagus twins have the highest rate [73]. 
Rachipagus is extremely rare with limited outcome data, and cephalopagus has 
extensive cerebral fusion that cannot be separated. Postnatal management typically 
includes non-operative management with comfort care, emergency separation, or 
planned elective separation, which ideally occurs at 2–4 months of age [68]. 
 
CONCLUSION 
All twin gestations have an increased risk of prematurity and other adverse events. 
Although prematurity is responsible for most of the morbidity and mortality observed 
among multiple gestations, monochorionic gestations have a markedly higher risk of 
adverse events. These problems are secondary to the considerably increased risk of 
congenital anomalies, sIUGR, and TTTS, which all potentially further increase the 
risk of prematurity. Although TRAP pregnancies, monochorionic/monoamniotic 
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gestations, and conjoined twins are all relatively rare, they have even more 
significant rates of morbidity and mortality. If a higher-order multiple gestation (i.e., 
triplets or more) is diagnosed, chorionicity for the whole gestation must be 
determined. A monochorionic pair can occur within the triplet or higher gestation and 
markedly increases the risk of complications within the pregnancy. A monochorionic 
twin pair within a higher-order multiple gestation should be followed in the same way 
as any monochorionic twin pair.  
 
The use of ultrasonography to appropriately diagnose twin gestations is central to 
providing proper counseling and care to parents presenting with a multiple gestation. 
An abbreviated overview of ultrasonography management is presented in Table 4. 
There must be a strong recognition that “twins” is an incomplete label: the diagnosis 
must include chorionicity—namely, dichorionic, monochorionic, or unknown (for 
women who present late for evaluation) [75]. Once a correct diagnosis is made, the 
optimal care for the pregnancy can be delineated. This care should aim to provide 
counseling about the true risks for the gestation, to establish accurate expectations, 
and to pursue the appropriate ultrasonography surveillance to optimize the outcome 
of the pregnancy. 
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Table 1 Time of splitting in cases of monozygotic twinning.
Embryo splitting time, d 
 a
 
Frequency in spontaneous twin Placentation 
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pregnancy, % 
1–3 30 Dichorionic/diamniotic 
4–7 70 Monochorionic/diamniotic 
8–12 <2 Monochorionic/monoamniotic 
13–16 <1 Conjoined twins 
a 
 
Data from [3]. 
Table 2 Classification of twin-to-twin transfusion.
Stage 
 a
 
Ultrasonography findings 
1 Polyhydramnios (MVP >8 cm) in 
recipient; oligohydramnios (MVP <2 cm) 
in donor 
2 Absent bladder in donor for 60 min 
3 Abnormal Doppler measurements  
4 Hydrops of one or both fetuses 
5 Death of one or both fetuses 
Abbreviation: MVP, maximal vertical pocket. 
a 
 
Data from [41]. 
Table 3 Classification of twin anemia polycythemia sequence.
Stage 
 a
 
Ultrasonography findings 
1 PSV of MCA >1.5 MoM in donor;  
PSV of MCA <1.0 MoM in recipient 
2 PSV of MCA >1.7 MoM in donor;  
PSV of MCA <0.8 MoM in recipient 
3 Cardiac compromise of the donor (critically 
abnormal flow) 
4 Hydrops of donor 
5 Intrauterine demise of one or both fetuses 
preceded by TAPS 
Abbreviations: PSV, peak systolic velocity; MCA, middle cerebral artery; MoM, multiple of the median; 
TAPS, twin anemia polycythemia sequence. 
 a 
 
Data from [45]. 
 
Table 4 General guidelines for ultrasonography imaging in twin pregnancies. 
Trimester Dichorionic/ 
diamniotic 
Dichorionic/ 
monoamniotic 
Monochorionic/ 
monoamniotic 
Conjoined 
First  Document chorionicity Document 
chorionicity/ 
Document chorionicity/ 
amnionicity 
Document  
chorionicity/ 
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amnionicity amnionicity 
 Document viability Document viability; 
check for reverse 
arterial flow if one 
fetus demised  
Document viability Viability 
 Establish dating based 
on larger CRL 
Dating Dating Dating 
 Offer first-trimester 
screening 
Offer first-trimester 
screening 
Offer first-trimester screening  
Second  Anatomy scan at 18–
20 wk 
Serial scans every 
2 wk to assess for 
TTTS beginning at 
16 wk 
Serial scans beginning at 16 
wk to assess for viability and 
TTTS 
Anatomy scan at 
18–20 wk and 
assess for viability 
 Growth scans every 4–
6 wk with more 
frequent assessment if 
anomalies present
If TRAP, check size 
of acardiac twin 
relative to pump 
twin
 b
 
Anatomy scan at 18–20 wk 
 a
 
Fetal echo 
  Weekly scans if 
discordant growth
 b
 
or fluid
Anatomy scan at 
18–20 wk 
 c 
Fetal echo Possible MRI 
  Fetal echo   
Third  Continue 4–6-wk 
growth scans with 
further assessment as 
indicated by anomalies 
Continue 1–2-wk 
scans depending 
on growth and fluid 
Continue 2-wk scans to assess 
for growth and/or TTTS 
Continue scans 
every 4 wk to follow 
polyhydramnios, 
and assess fetal 
status and/or 
growth 
  Consider PSV of 
the MCA to screen 
for TAPS  
Consider more intensive 
surveillance when EFW and 
gestational age consistent with 
viability and patient wishes  
Consider fetal MRI 
if felt helpful to 
better define 
anatomy  
Abbreviations: CRL, crown–rump length; EFW, estimated fetal weight; IUGR, intrauterine growth 
restriction; MCA, middle cerebral artery; MRI, magnetic resonance imaging; PSV, peak systolic 
velocity; TAPS, twin anemia polycythemia sequence; TRAP; twin reversed arterial–perfusion; TTTS, 
twin-to-twin transfusion syndrome; IUGR, intrauterine growth restriction. 
a 
If TRAP shows an acardiac twin >50% of pump twin size, offer a procedure to stop flow to acardiac 
twin. 
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b 
Umbilical artery Doppler assessment should be performed if evidence of IUGR for one or both twins; 
additional Doppler assessment of MCA or ductus venosus should be performed as in the case of 
singleton gestation with IUGR. 
c 
 
If diagnosis of TTTS, offer selective fetoscopic laser ablation or other treatment.
 
Figure 1 Dichorionic pregnancy at 7 weeks of gestation. Note the thick echogenic 
chorion surrounding each embryo and between the embryos, labeled A and B.  
Figure 2 Twin peak (lambda) sign in a dichorionic pregnancy. Arrow indicates the 
twin peak, which separates the two embryos labeled A and B. Note the extension of 
the placenta into the intervening membrane.  
Figure 3 Diamniotic/monochorionic pregnancy at 6–7 weeks of gestation. The single 
chorion and two separate amnions (indicated by arrows) are visible. Note the 
absence of placenta extending into intervening membrane. 
Figure 4 Diamniotic/monochorionic pregnancy in the first trimester. Arrow indicates 
the intervening diamniotic membrane separating the two embryos, labeled A and B.  
Figure 5 T sign in a diamniotic/monochorionic twin gestation. Note the absence of 
chorion extending between the layers of the intertwin membrane, which comes to an 
abrupt halt at the edge in a T configuration (indicated by arrow).  
Figure 6 Monoamniotic/monochorionic pregnancy at 13 weeks of gestation. There is 
no intervening membrane and the fetal calvariae are immediately adjacent to each 
other. 
Figure 7 Cord entanglement in a monoamniotic/monochorionic pregnancy. The 
twins’ cords are labeled AA and BB. 
Figure 8 Transvaginal ultrasonography of vasa previa. Note the fetal vessels 
traversing across the internal cervical os (indicated by arrow).  
Figure 9 Monochorionic/diamniotic twin gestation complicated by twin-to-twin 
transfusion syndrome. Arrow indicates the intertwin membrane. Polyhydramnios can 
be seen for fetus A, while fetus B demonstrates the “stuck twin” phenomenon with 
oligohydramnios. 
Figure 10 Monochorionic twin gestation with proximate cord insertions into the 
placenta. 
Figure 11 Monochorionic/diamniotic twin gestation complicated by reversed end 
diastolic flow in the umbilical artery, categorized as type II selective intrauterine 
growth restriction [52].  
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Figure 12 Retrograde blood flow into the acardiac twin in a case of twin reversed 
arterial perfusion sequence. 
Figure 13 Monoamniotic/monochorionic twin gestation in the second trimester with 
cord entanglement. 
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